Race Oncology Ltd   Report issue

For profit Phase 2
Founded: Melbourne Australia (1993)

Organization Overview

First Clinical Trial
2019
NCT03820908
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Race Oncology Ltd